PINK
Simplify Health Care ETF
NAV as of
4 Week: 37.56 - 40.89
52 Week: 32.04 - 40.89
Latest Closing Price
38.92
Premium / Discount
-0.08
Expense Ratio
0.51%
Investment Objective
The investment seeks long-term capital appreciation. Under normal circumstances, the fund will invest at least 80% of its assets (plus any borrowings for investment purposes) in securities of U.S. health care companies. The fund adviser defines health care companies as companies included in the Global Industry Classification Standard health care sector. The fund will typically invest in 50 – 100 health care companies. The adviser generally seeks investments in companies that are developing new and effective medicines, as well as companies whose business models reduce costs or improve quality in health care systems.
Main Fund Characteristics
Performance
| Period | Performance Returns(%) | Volatility(%) | Risk Adjusted Performance |
|---|---|---|---|
| YTD | 6.34 | 1.21 | 5.26 |
| 1 Day | -4.82 | 0.00 | 0.00 |
| 1 Week | -4.72 | 5.57 | -0.85 |
| 1 Month | 1.30 | 7.84 | 0.17 |
| 3 Months | -1.92 | 10.01 | -0.19 |
| 6 Months | 11.77 | 12.85 | 0.92 |
| 1 Year | 18.33 | 19.05 | 0.96 |
| 2 Years | 21.66 | 26.74 | 0.81 |
| 3 Years | 57.51 | 30.10 | 1.91 |
| 5 Years | 47.40 | 39.28 | 1.21 |
| 10 Years | 0.00 | 0.00 | 0.00 |
Price History
Annual Performance Return
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | |
| Price (%) | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | -4.2713 | 3.7520 | 8.8721 | 24.0703 |
| Nav (%) | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 |
| Rank | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 17.0000 | 46.0000 | 5.0000 | 33.0000 |
Dividend Frequency
Lastest Dividend
| Ex Date | Payment Date | Dividend Payout per unit |
|---|---|---|
| 25/09/2026 | 30/09/2026 | 0.1000 |
Portfolio Data
Total Number of Holdings: 53
Number of Bond Holdings: 0
Number of Equity Holdings: 52
Total Market Value: 345,955,272
Portfolio Composition
Top 10 Holdings
| % Portfolio Weight | Shares Owned | Shares Changed | Market Value | ||
|---|---|---|---|---|---|
| 1 | Arcutis Biotherapeutics Inc Ordinary Shares | 7.9894 | 811,740 | 0 | 27,639,747 |
| 2 | Johnson & Johnson | 7.4292 | 93,014 | 0 | 25,701,628 |
| 3 | Humana Inc | 7.3810 | 61,173 | 0 | 25,534,834 |
| 4 | United Therapeutics Corp | 6.6272 | 37,679 | 0 | 22,927,295 |
| 5 | Eli Lilly and Co | 5.3210 | 12,982 | 0 | 18,408,346 |
| 6 | AbbVie Inc | 5.1428 | 60,346 | 0 | 17,791,811 |
| 7 | Thermo Fisher Scientific Inc | 4.6290 | 22,678 | 0 | 16,014,296 |
| 8 | UnitedHealth Group Inc | 4.5529 | 38,475 | 0 | 15,750,896 |
| 9 | Gilead Sciences Inc | 3.8397 | 76,133 | 0 | 13,283,686 |
| 10 | Avantor Inc | 3.8203 | 844,500 | -62,569 | 13,216,425 |
Country Exposure
Regional Exposure
America
Greater Europe
Greater Asia
Market Classification
Market Capitalization
| Size | % of portfolio |
|---|---|
| Giant | 5.33 |
| Large | 32.34 |
| Medium | 26.67 |
| Small | 21.05 |
| Micro | 11.48 |
Equity Style Box Breakdown
| 0 | 0 | 0 | Large |
| 0 | 0 | 0 | Mid |
| 0 | 0 | 0 | Small |
| Value | Blend | Growth |
Value Measures
Price/Prospective Earnings*
19.7911
Price/Book*
3.8665
Price/Sales*
1.3625
Price/Cash Flow*
16.0098
Dividend Yield*
0.7744
Growth Measures
Long-Term Earnings
11.4273
Historical Earnings
11.5617
Sales Growth
10.3616
Cash-Flow Growth
6.6132
Book-Value Growth
-0.4526
*Forward-looking based on historical data.
Equity Sector
Number of Bond Holdings
0
Bond Statitics
| Detail | Value |
|---|---|
| Average Effective Duration | 9.74 |
| Average Effective Maturity (Years)* | 0 |
| Average Credit Quality | 4.00 |
| Average Weighted Coupon* | 0 |
| Average Weighted Price* | 0 |
Bond Style Box Breakdown
| 0 | 0 | 0 | High | Quality |
| 0 | 0 | 0 | Med | |
| 0 | 0 | 0 | Low | |
| Ltd | Mod | Ext | ||
| Interest-Rate Sensitivity | ||||
Credit Quality
| Type | % Bonds |
|---|---|
| AAA | 0.00 |
| AA | 100.00 |
| A | 0.00 |
| BBB | 0.00 |
| BB | 0.00 |
| B | 0.00 |
| Below B | 0.00 |
| Not Rated | 0.00 |
Bond Sector
Bond Maturity
| % Bonds | |
|---|---|
| 1 to 3 Years | 0.00 |
| 3 to 5 Years | 0.00 |
| 5 to 7 Years | 0.00 |
| 7 to 10 Years | 0.00 |
| 10 to 15 Years | 0.00 |
| 15 to 20 Years | 0.00 |
| 20 to 30 Years | 0.00 |
| Over 30 Years | 0.00 |
| 1 to 7 Days | 0.00 |
| 8 to 30 Days | 0.00 |
| 31 to 90 Days | 0.00 |
| 91 to 182 Days | 0.00 |
| 183 to 364 Days | 0.04 |
Data Source: Morningstar
© 2019 Morningstar. All Rights Reserved. The information, data, analyses and opinions (“Information”) contained herein:
(2) may not be copied or redistributed except as specifically authorised;
(3) do not constitute investment advice;
(4) are provided solely for informational purposes;
(5) are not warranted to be complete, accurate or timely; and
(6) may be drawn from fund data published on various dates.
Morningstar and Phillip Securities Pte Ltd are not responsible for any trading decisions, damages or other losses related to the Information or its use. Please verify all of the Information before using it and don’t make any investment decision except upon the advice of a professional financial adviser. Past performance is no guarantee of future results. The value and income derived from investments may go down as well as up.
For the most up-to-date fund’s data and information, a copy of the fund factsheet, information or prospectus may be obtained from the respective ETF issuer.
